NASDAQ:EVFM
Evofem Biosciences Stock News
$0.0139
-0.0001 (-0.714%)
At Close: May 01, 2024
SAN DIEGO, April 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi® (lactic acid, citric acid,
Evofem Biosciences to Report First Quarter 2021 Results and Provide Corporate Update on Thursday, May 6, 2021
08:00am, Thursday, 22'nd Apr 2021
SAN DIEGO, April 22, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the
Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum
08:00am, Wednesday, 21'st Apr 2021
SAN DIEGO, April 21, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced the company will deliver the keynote address and present two poster presentations on Phexxi® (lacti
Evofem Biosciences Announces Closing of Public Offering of Common Stock
04:05pm, Monday, 29'th Mar 2021
SAN DIEGO, March 29, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 17,142,857 shares of its commo
Why Cellect, Immutep, F-star, ProQR and Evofem Are Moving Thursday
12:22pm, Thursday, 25'th Mar 2021
Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.
Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common Stock
10:00pm, Wednesday, 24'th Mar 2021
SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price t
Evofem Biosciences Announces Proposed Public Offering of Common Stock
04:00pm, Wednesday, 24'th Mar 2021
SAN DIEGO, March 24, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell, subject to market and other conditions, $30 million of shares of i
Evofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact
08:00am, Wednesday, 17'th Mar 2021
SAN DIEGO, March 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that "Get Phexxi," its national direct-to-consumer (DTC) campaign aimed at broadening awareness of
7 Stocks for Sale That Have Insider Buying
11:51am, Tuesday, 16'th Mar 2021
Insiders sell for many reasons, but they only buy for one. To make money.
SAN DIEGO, March 16, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced publication of the pivotal manuscript from the AMPREVENCE clinical trial in the highly respected Ame
EVFM Stock Price Increased 18.94%: Why It Happened
11:55pm, Wednesday, 10'th Mar 2021
The stock price of Evofem Biosciences Inc (NASDAQ: EVFM) increased by 18.94%. This is why it happened.
Evofem Biosciences Launches Phexxi: Will Peak Sales Surprise?
05:03pm, Tuesday, 09'th Mar 2021
Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant side
Why Evofem Biosciences Stock Is Falling Today
01:00pm, Friday, 05'th Mar 2021
The company's performance during the fourth quarter was short of expectations.
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2020 Results - Earnings Call Transcript
10:15pm, Thursday, 04'th Mar 2021
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2020 Results - Earnings Call Transcript
Evofem Biosciences: Q4 Earnings Insights
05:28pm, Thursday, 04'th Mar 2021
Shares of Evofem Biosciences (NASDAQ:EVFM) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 85.19% over the past year to ($0.50)